The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mcnally James B. since 2017.
The trader's CIK number is 1688737.
At the time of the last reporting, Mcnally James B. was the SVP, Marketing & Bus Dev of Genmark Diagnostics, Inc.. (stock ticker symbol GNMK).
Also see all insider trading activities at Genmark Diagnostics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | GNMK | 0 | $0 | 28,489 | $181,337 | 11,428 | $0 |
2018 | GNMK | 0 | $0 | 5,678 | $30,725 | 0 | $0 |
2017 | GNMK | 0 | $0 | 3,084 | $22,328 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-11-25 | GNMK | Sale | 2,288 | 5.43 | 12,423 |
2019-11-05 | GNMK | Sale | 938 | 5.68 | 5,327 |
2019-10-30 | GNMK | Sale | 1,718 | 5.88 | 10,101 |
2019-08-27 | GNMK | Sale | 2,296 | 6.03 | 13,844 |
2019-08-05 | GNMK | Sale | 1,006 | 5.87 | 5,905 |
2019-05-30 | GNMK | Sale | 2,057 | 6.60 | 13,576 |
2019-05-24 | GNMK | Sale | 231 | 6.62 | 1,529 |
2019-05-03 | GNMK | Sale | 928 | 7.79 | 7,229 |
2019-02-25 | GNMK | Sale | 12,297 | 6.79 | 83,496 |
2019-01-23 | GNMK | Sale | 4,730 | 5.90 | 27,907 |
2019-01-17 | GNMK | Option Ex | 11,428 | .00 | 0 |
2018-11-27 | GNMK | Sale | 219 | 5.08 | 1,112 |
2018-11-05 | GNMK | Sale | 1,644 | 4.85 | 7,973 |
2018-08-24 | GNMK | Sale | 230 | 7.16 | 1,646 |
2018-08-03 | GNMK | Sale | 680 | 7.20 | 4,896 |
2018-05-23 | GNMK | Sale | 216 | 6.88 | 1,486 |
2018-05-02 | GNMK | Sale | 789 | 6.18 | 4,876 |
2018-02-26 | GNMK | Sale | 1,052 | 4.17 | 4,386 |
2018-02-02 | GNMK | Sale | 848 | 5.13 | 4,350 |
2017-11-02 | GNMK | Sale | 3,084 | 7.24 | 22,328 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcnally James B. (SVP, Marketing & Bus Dev of Genmark Diagnostics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.